Bruker (BRKR) Consolidated Net Income (2010 - 2026)
Bruker's (BRKR) quarterly Consolidated Net Income came in at $15.4 million in Q1 2026, down 9.94% YoY from $17.1 million in Q1 2025, and up 124.56% on a QoQ basis from -$62.7 million in Q4 2025.
Bruker (BRKR) Consolidated Net Income (2010 - 2026) Analysis & Trends
Bruker (BRKR) has 17 years of Consolidated Net Income data on file, last reported at $15.4 million in Q1 2026.
- Quarterly Consolidated Net Income fell 9.94% year-over-year to $15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (up 114.29% YoY) and the FY2025 annual result came in at $8.0 million, up 107.05% from the prior year.
- Consolidated Net Income grew to $15.4 million in Q1 2026, from -$62.7 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $98.5 million in Q4 2022 to a low of -$654.0 million in Q4 2023.
- A 5-year average of -$13.0 million and a median of $17.1 million in 2025 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2023 — Consolidated Net Income plunged 763.96% — and 2025, when it jumped 247.16%.
- Tracing BRKR's Consolidated Net Income over 5 years: stood at $98.5 million in 2022, then sank by 763.96% to -$654.0 million in 2023, then surged by 98.04% to -$12.8 million in 2024, then tumbled by 389.84% to -$62.7 million in 2025, then soared by 124.56% to $15.4 million in 2026.
- The last three Consolidated Net Income figures came in at $15.4 million (Q1 2026), -$62.7 million (Q4 2025), and $59.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Bruker | 9.13 Bn | 9.13 Bn | 416.00 Mn | -65.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -51.00 Mn |
| Mar 31, 2026 | 15.40 Mn |
| Dec 31, 2025 | -62.70 Mn |
| Sep 30, 2025 | 59.60 Mn |
| Jun 30, 2025 | -6.00 Mn |
| Mar 31, 2025 | 17.10 Mn |
| Dec 31, 2024 | -12.80 Mn |
| Sep 30, 2024 | -40.50 Mn |
| Jun 30, 2024 | -7.90 Mn |
| Mar 31, 2024 | -52.30 Mn |
| Dec 31, 2023 | -654.00 Mn |
| Sep 30, 2023 | 89.10 Mn |
| Jun 30, 2023 | 58.20 Mn |
| Mar 31, 2023 | 77.50 Mn |
| Dec 31, 2022 | 98.50 Mn |
| Sep 30, 2022 | 88.60 Mn |
| Jun 30, 2022 | 49.90 Mn |
| Mar 31, 2022 | 62.10 Mn |
| Dec 31, 2021 | 485.30 Mn |
| Sep 30, 2021 | -88.10 Mn |